Phenytoin 30mg/5ml Oral Suspension
Liquid oral suspension with 30mg phenytoin per 5ml, suitable for pediatric seizure control. Under HTS 3004.90.92.41 for its retail-packed, measured-dose form as a central nervous system anticonvulsant containing phenytoin salts.
Import Duty Rates by Country of Origin
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If unmixed phenytoin solution in measured doses
Unmixed products dissolved in water are treated as unmixed under chapter notes for 3003.
If mineral water-based without therapeutic claim
Natural mineral water concentrates go to Chapter 22, excluding medicinal uses.
If other medicaments not primarily CNS-acting
Heading specifies primary therapeutic effect on central nervous system.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Ensure child-resistant packaging and shake-well labeling for suspensions
• Validate preservative efficacy to meet microbial limits
Related Products under HTS 3004.90.92.41
Levetiracetam 500mg Tablets
Oral tablets containing 500mg of levetiracetam, an anticonvulsant used to treat partial-onset seizures in adults and children. This product falls under HTS 3004.90.92.41 as it is a measured dose medicament primarily affecting the central nervous system, specifically containing levetiracetam for therapeutic use.
Phenytoin Sodium 100mg Capsules
Extended-release capsules with 100mg phenytoin sodium, used for controlling tonic-clonic and partial seizures. Classified under HTS 3004.90.92.41 due to its retail packaging in measured doses as a sedative anticonvulsant affecting the central nervous system.
Levetiracetam 250mg Oral Solution
Sweetened oral solution at 250mg per dose for pediatric and geriatric epilepsy treatment. Falls under HTS 3004.90.92.41 for its prophylactic CNS anticonvulsant use in retail measured forms.
Levetiracetam and Phenytoin Combo Tablets
Combination tablets with both levetiracetam and phenytoin salts for refractory epilepsy. HTS 3004.90.92.41 applies as mixed CNS anticonvulsants in retail measured doses.
Levetiracetam 1000mg Extended-Release Tablets
Extended-release tablets providing 1000mg levetiracetam for once-daily dosing in epilepsy management. This fits HTS 3004.90.92.41 as a mixed product in measured doses for retail sale, targeting central nervous system anticonvulsant therapy.
Levetiracetam 750mg Film-Coated Tablets
Film-coated tablets delivering 750mg levetiracetam, used adjunctively for myoclonic seizures. Classified in HTS 3004.90.92.41 as a finished retail product in measured doses for anticonvulsant prophylaxis.